The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

被引：204
|
作者：
Nichol, KL [1 ]
机构：
[1] Univ Minnesota, VA Med Ctr, Minneapolis, MN 55417 USA
来源：
VACCINE | 2003年 / 21卷 / 16期
关键词：
efficacy; influenza; vaccination; cost effectiveness;
D O I：
10.1016/S0264-410X(03)00070-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Influenza is a major cause of morbidity and mortality worldwide. Currently available inactivated influenza virus vaccines are safe and effective in preventing influenza. Substantial health benefits are seen across all age and risk groups. Studies assessing the economic benefits of vaccination suggest that vaccination is highly cost effective and in many cases cost saving among the elderly. Influenza vaccination has also been associated with significant economic benefits in younger adults and children. Additional health economic studies from developing countries and from tropical/subtropical regions will be vitally important for better understanding of the global burden of influenza and potential benefits of vaccination. Published by Elsevier Science Ltd.
引用
收藏
页码：1769 / 1775
页数：7
相关论文
共 50 条
  • [41] INACTIVATED INFLUENZA VIRUS VACCINES
    HOBSON, D
    JOURNAL OF GENERAL MICROBIOLOGY, 1964, 37 (02): : R9 - &
  • [42] Influenza cost and cost-effectiveness studies globally - A review
    Peasah, Samuel K.
    Azziz-Baumgartner, Eduardo
    Breese, Joseph
    Meltzer, Martin I.
    Widdowson, Marc-Alain
    VACCINE, 2013, 31 (46) : 5339 - 5348
  • [43] Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
    Mattock, Richard
    Gibbons, Ilana
    Moss, Joe
    Mealing, Stuart
    Largeron, Nathalie
    Carroll, Stuart
    Alvarez, Fabian P.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1261 - 1271
  • [44] Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability
    Hendriks, Jan
    Hutubessy, Raymond C. W.
    Grohmann, Gary
    Torelli, Guido
    Friede, Martin
    Kieny, Marie-Paule
    VACCINE, 2018, 36 (28) : 3993 - 3997
  • [45] The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysis
    Waterlow, Naomi R.
    Procter, Simon R.
    van Leeuwen, Edwin
    Radhakrishnan, Sreejith
    Jit, Mark
    Eggo, Rosalind M.
    VACCINE, 2023, 41 (41) : 6017 - 6024
  • [46] Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review
    Valcarcel Nazco, Cristina
    Garcia Lorenzo, Borja
    del Pino Sedeno, Tasmania
    Garcia Perez, Lidia
    Brito Garcia, Noe
    Linertova, Renata
    Ferrer Rodriguez, Jorge
    Imaz Iglesia, Inaki
    Serrano Aguilar, Pedro
    REVISTA ESPANOLA DE SALUD PUBLICA, 2018, 92
  • [47] Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age
    Kittikraisak, Wanitchaya
    Suntarattiwong, Piyarat
    Ditsungnoen, Darunee
    Pallas, Sarah E.
    Abimbola, Taiwo O.
    Klungthong, Chonticha
    Fernandez, Stefan
    Srisarang, Suchada
    Chotpitayasunondh, Tawee
    Dawood, Fatimah S.
    Olsen, Sonja J.
    Lindblade, Kim A.
    PLOS ONE, 2017, 12 (08):
  • [48] THE POTENTIAL COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INACTIVATED INFLUENZA VACCINE FOR THE PORTUGUESE ELDERLY POPULATION
    Tavares, D.
    Martin Saborido, C.
    Mourino, H.
    Anton Rodriguez, C.
    VALUE IN HEALTH, 2019, 22 : S651 - S652
  • [49] DAY HOSPITAL - EFFICACY AND COST-EFFECTIVENESS
    RIDINGS, KW
    ISDALE, IC
    NEW ZEALAND MEDICAL JOURNAL, 1978, 87 (606) : 129 - 133
  • [50] IMMUNOLOGICAL EFFECTIVENESS OF SIMULTANEOUS IMMUNIZATION AGAINST INFLUENZA WITH LIVE AND INACTIVATED VACCINES
    ORLOV, VA
    ZHILOVA, GP
    IGNATIEVA, GS
    MALIKOVA, EV
    EFREMOV, BV
    ERMOLAEVA, OM
    SHADRIN, AS
    SMORODINTSEV, AA
    VOPROSY VIRUSOLOGII, 1982, (03) : 271 - 275
12345